« Back
Home /
ap-24567

ap-24567

Item no.	V11428-100mg
Manufacturer	InvivoChem LLC
CASRN	943319-87-7
Amount	100 mg
Quantity options	1 g 250 mg 500 mg 50 mg
Category	Reagents & Chemicals Molecules
Type	Biochemicals
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Description	InvivoChem Cat #:V11428CAS #:943319-87-7Purity >=98% Description: AP-24567, formerly known as N-Desmethyl ponatinib, is a major metabolite of ponatinib by the action of CYP3A4. It is 4-fold less potent than ponatinib. Ponatinib (AP24534) is a BCR?ABL tyrosine kinase inhibitor (TKI) approved by FDA for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positiveacute lymphoblastic leukemia in patients resistant or intolerant to prior TKIs. In vitro studies suggested that metabolism of ponatinib is partially mediatedby CYP3A4. AP24534) References: Narasimhan NI, Dorer DJ, Niland K, Haluska F, Sonnichsen D. Effects of ketoconazole on the pharmacokinetics of ponatinib in healthy subjects. J Clin Pharmacol. 2013 Sep; 53(9):974-81. doi: 10.1002/jcph.109. Epub 2013 Jun 25. PubMed PMID: 23801357; PubMed Central PMCID: PMC3781849.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 9/4/2025

Express Delivery: Save 14 days

Compare

Add to wishlist

Get an offer